Eversept Partners, LP United Therapeutics Corp Transaction History

Eversept Partners, LP

  • $904 Million
  • Q1 2025

A detailed history of Eversept Partners, LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Eversept Partners, LP holds 57,489 shares of UTHR stock, worth $18.1 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares
57,489
Previous 43,703 31.54%
Holding current value
$18.1 Million
Previous $15.4 Million 14.93%
% of portfolio
1.96%
Previous 1.56%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$304.42 - $380.78 $4.2 Million - $5.25 Million
13,786 Added 31.54%
57,489 $17.7 Million
Q4 2024

Feb 14, 2025
SELL
$348.66 - $410.0 $30.4 Million - $35.8 Million
-87,246 Reduced 66.63%
43,703 $15.4 Million
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $32.5 Million - $38 Million
-104,402 Reduced 44.36%
130,949 $46.9 Million
Q2 2024

Aug 14, 2024
SELL
$228.26 - $319.04 $3.6 Million - $5.04 Million
-15,784 Reduced 6.29%
235,351 $75 Million
Q1 2024

May 15, 2024
BUY
$210.76 - $249.51 $1.03 Million - $1.22 Million
4,901 Added 1.99%
251,135 $57.7 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $4.66 Million - $5.57 Million
-21,669 Reduced 8.09%
246,234 $54.1 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $1.59 Million - $1.86 Million
7,505 Added 2.88%
267,903 $60.5 Million
Q2 2023

Nov 08, 2023
BUY
$205.19 - $232.99 $7.86 Million - $8.92 Million
38,291 Added 17.24%
260,398 $57.5 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $7.86 Million - $8.92 Million
38,291 Added 17.24%
260,398 $57.5 Million
Q1 2023

Nov 08, 2023
SELL
$212.99 - $276.17 $2.27 Million - $2.95 Million
-10,680 Reduced 4.59%
222,107 $49.7 Million
Q1 2023

May 15, 2023
SELL
$212.99 - $276.17 $2.27 Million - $2.95 Million
-10,680 Reduced 4.59%
222,107 $49.7 Million
Q4 2022

Nov 08, 2023
SELL
$205.95 - $280.43 $4.62 Million - $6.29 Million
-22,439 Reduced 8.79%
232,787 $64.7 Million
Q4 2022

Feb 14, 2023
SELL
$205.95 - $280.43 $4.62 Million - $6.29 Million
-22,439 Reduced 8.79%
232,787 $64.7 Million
Q3 2022

Nov 08, 2023
SELL
$203.3 - $244.17 $11.3 Million - $13.6 Million
-55,608 Reduced 17.89%
255,226 $53.4 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $11.3 Million - $13.6 Million
-55,608 Reduced 17.89%
255,226 $53.4 Million
Q2 2022

Nov 08, 2023
BUY
$174.81 - $241.14 $3.25 Million - $4.49 Million
18,600 Added 6.36%
310,834 $73.2 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $3.25 Million - $4.49 Million
18,600 Added 6.36%
310,834 $73.2 Million
Q1 2022

Nov 08, 2023
BUY
$166.16 - $213.96 $5.29 Million - $6.81 Million
31,836 Added 12.23%
292,234 $52.4 Million
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $16.6 Million - $21.3 Million
-99,686 Reduced 25.44%
292,234 $52.4 Million
Q4 2021

Nov 08, 2023
SELL
$184.32 - $216.08 $9.69 Million - $11.4 Million
-52,551 Reduced 11.82%
391,920 $84.7 Million
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $9.69 Million - $11.4 Million
-52,551 Reduced 11.82%
391,920 $84.7 Million
Q3 2021

Nov 08, 2023
BUY
$179.86 - $214.88 $274,466 - $327,906
1,526 Added 0.34%
444,471 $82 Million
Q3 2021

Nov 15, 2021
BUY
$179.86 - $214.88 $274,466 - $327,906
1,526 Added 0.34%
444,471 $82 Million
Q2 2021

Nov 08, 2023
SELL
$170.47 - $211.93 $7.43 Million - $9.24 Million
-43,584 Reduced 8.96%
442,945 $79.5 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $7.43 Million - $9.24 Million
-43,584 Reduced 8.96%
442,945 $79.5 Million
Q1 2021

Nov 08, 2023
BUY
$153.94 - $174.85 $4.29 Million - $4.88 Million
27,893 Added 6.08%
486,529 $81.4 Million
Q1 2021

May 13, 2021
BUY
$153.94 - $174.85 $4.29 Million - $4.88 Million
27,893 Added 6.08%
486,529 $81.4 Million
Q4 2020

Nov 08, 2023
BUY
$101.87 - $151.79 $20.2 Million - $30.1 Million
198,238 Added 76.13%
458,636 $69.6 Million
Q4 2020

Feb 16, 2021
BUY
$101.87 - $151.79 $22.2 Million - $33 Million
217,732 Added 90.38%
458,636 $69.6 Million
Q3 2020

Nov 08, 2023
BUY
$99.9 - $121.13 $821,977 - $996,657
8,228 Added 3.54%
240,904 $24.3 Million
Q3 2020

Nov 13, 2020
BUY
$99.9 - $121.13 $821,977 - $996,657
8,228 Added 3.54%
240,904 $24.3 Million
Q2 2020

Nov 08, 2023
SELL
$92.74 - $125.82 $2.57 Million - $3.49 Million
-27,722 Reduced 10.65%
232,676 $28.2 Million
Q2 2020

Aug 13, 2020
BUY
$92.74 - $125.82 $21.6 Million - $29.3 Million
232,676 New
232,676 $28.2 Million

Others Institutions Holding UTHR

# of Institutions
733
Shares Held
43.6M
Call Options Held
124K
Put Options Held
122K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email